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Acta Crystallographica Section C is pleased to announce the publication of its ﬁrst virtual
issue. The issue is dedicated to the subject of polymorphism (http://journals.iucr.org/
special_issues/2011/polymorphism/) and includes papers relating to this topic published
in Section C between January 2010 and November 2011. In putting the issue together, the
term polymorph has been taken to include materials that are pseudopolymorphs
(solvates), solvatomorphs or referred to as having different phases or modiﬁcations. The
latter terms are in more common usage with inorganic materials. Structure reports of
cocrystals involving variations in nonsolvent components have not been included, but a
future virtual issue on the topic of cocrystals is being planned.
The concept of virtual issues of Section C is a new initiative designed to make it easier
for readers to ﬁnd papers relevant to their ﬁeld of interest, thus increasing the visibility
and impact of those papers, and consequently the attractiveness of the journal to authors.
The rapid publication style of the journal does not lend itself easily to the production of
formal special issues for which long lead times or the holding over of relevant submis-
sions is required. Nevertheless, online publishing readily facilitates the creation of virtual
issues, which can be used to bring together and highlight papers on speciﬁc topics that
have recently been published in the journal. The contents page of the virtual issue then
provides suitable links to the original papers.
Polymorphism, particularly for molecular materials, was perhaps once considered a
curiosity. In routine crystal structure determination, one frequently looked for the ﬁrst
good crystal one could ﬁnd, determined its structure and then did not pursue the matter
further because the nature of the chemical species had been established. Polymorphs
were usually only found serendipitously if one happened to notice different crystal forms
in a batch of crystals, or if different crystallization conditions were employed, possibly
even at different times by different laboratories.
Nowadays, polymorphism has become a crucial issue for the pharmaceutical industry.
Different polymorphs of a drug can have quite different properties in terms of solubility,
bioavailability, shelf life, ease of production, and other physical properties. The unex-
pected appearance of a new polymorph during production of a drug has led to several
famous examples affecting dosage or drug effectiveness, with potentially dire conse-
quences. Therefore, during the development of new drugs in solid form, pharmaceutical
companies now have to invest considerable effort to ensure that they are aware of all
possible polymorphs before they can receive regulatory approval. In addition, because of
the peculiarities of patenting laws, pharmaceutical companies want to protect their
intellectual property by patenting as many polymorphs as possible, while competitors
seek to bypass the patents by ﬁnding new polymorphs or pseudopolymorphs.
Developments in crystal structure prediction in recent years have also highlighted that
hitherto unknown polymorphs with very favourable energy, even the thermodynamically
lowest energy, may exist for some materials. Such prediction software has also aroused
the keen interest of the pharmaceutical industry to help them in their quest to ﬁnd all
possible polymorphs of a formulation.
The editors ofActa Crystallographica Section C hope that readers ﬁnd this virtual issue
interesting and beneﬁcial. The next virtual issue will be published in late 2012. Details
will be announced on the journal’s homepage at the beginning of 2012.
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